Cell Fractionation

Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030

  • Lowest Price Guaranteed From USD 4,499

  • Published
    August 2019

  • Pages
    519

  • View Count
    10622

Example Insights

Cell Fractionation - Context Cell Fractionation - Patent Analysis Cell Fractionation - Technologies
Cell Fractionation - Product and Solution Providers Cell Fractionation - Products and Solution Provider Cell Fractionation - Company Competitiveness Analysis
Cell Fractionation - Publication Analysis Cell Fractionation - Funding and Investments Cell Fractionation - Partnerships and Collaborations
Cell Fractionation - Market Analysis Cell Fractionation - Market Forecast 2030  

 

Report Description

The novel cell sorting and separation market is expected to be worth $227 million and is projected to rise to $2,305 million by 2030, growing at a compounded annual growth rate (CAGR) of 23.5%. Advances in the fields of cell biology and regenerative medicine have led to the development of various cell-based therapies, which, developers claim, possess the potential to treat a variety of clinical conditions. In 2018, it was reported that there were more than 1,000 clinical trials of such therapies, being conducted across the globe by over 900 industry players. Moreover, the total investment in the aforementioned clinical research efforts was estimated to be around USD 13 billion. Given the recent breakthroughs in clinical testing and the discovery of a variety of diagnostic biomarkers, the isolation of one or multiple cell types from a heterogenous population has not only become simpler, but also an integral part of modern clinical R&D. The applications of cell separation technologies are vast, starting from basic research to biological therapy development and manufacturing. However, conventional cell sorting techniques, including adherence-based sorting, membrane filtration-based sorting, and fluorescence- and magnetic-based sorting, are limited by exorbitant operational costs, time-consuming procedures, and the need for complex biochemical labels. As a result, the use of such techniques has, so far, been restricted in the more niche and emerging application areas. Specifically, in situations, such as the ongoing COVID-19 pandemic, healthcare organizations require precise cell analysis kits for timely detection of infections.

Over the years, extensive research in the field of flow cytometry has enabled the development of a variety of novel technologies that are capable of efficiently isolating cells from tissue samples and / or heterogenous cell populations. In fact, since 2014, over 3,000 patents were reported to have been filed / granted related to such advanced techniques, indicating the rapid pace of innovation in this domain. Developers of the aforementioned technologies claim that these new techniques offer numerous benefits, including fast and precise cell sorting, reduced sample requirement, improved portability, reduced risk to cell viability, and negligible need for expensive biochemical / magnetic labels. Moreover, they have been shown to be compatible for use across a myriad of applications, including research studies (bacteriology, immunology, stem cell research, and viral titering and infectivity), biomedical diagnostics (circulating tumor cell detection, in vitro fertilization, and non-invasive prenatal diagnosis), biological therapy-related process operations (bio-banking, drug discovery, sample preparation, single cell sequencing, and tumor cell characterization), and cell-based therapeutics (B- or T-cell immunotherapies). Consequently, these techniques have captured the interest of several stakeholders in the biopharmaceutical industry. It is also worth highlighting that stakeholders in this domain have received significant support from both private and public investors. 

Scope of the Report

The Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity, and Other Technologies, 2019-2030 report features an extensive study of the current landscape and future outlook of the growing market for novel cell sorting and separation technologies (beyond conventional methods). The study presents detailed analyses of cell sorters, cell isolation kits, and affiliated consumables and reagents, that are based on the aforementioned technologies. Amongst other elements, the report features:

  • A detailed assessment of the current market landscape, featuring a comprehensive list of over 220 innovative cell sorters, cell isolation kits, and affiliated consumables and reagents, along with information on their respective specifications (such as size, weight, cell flow rate, cell sort rate, cell analysis rate, cell purity and viability, process time, and operating temperature and pressure), cell sorting technology (acoustophoresis, buoyancy-activated, dielectrophoresis, magnetic levitation, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), type of cell (animal cells, cancer cells, immune cells, microbial cells, red blood cells / platelets, stem cells, and others), cell separation approach (positive selection, negative selection and depletion), basis for separation (cell morphology and physiology, cell size and density, surface biomarkers, surface charge and adhesion, and others), and end use / application (research studies, biomedical diagnostics, biological therapy-related process operations, and cell-based therapeutics).
  • An insightful company competitiveness analysis, taking into consideration the supplier power (based on size of employee base and experience in this segment of the industry) and portfolio-related parameters, such as number of products offered, number of target cells, end use(s) / application(s), and key product specification(s).  
  • Comprehensive profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are currently offering novel cell sorters / consumables and cell isolation kits, featuring an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth in the foreseen future.
  • An in-depth analysis of the patents that have been filed / granted related to novel cell sorting and separation technologies, since 2014. It highlights the key trends associated with these patents, across patent type, regional applicability, CPC classification, emerging focus areas, leading industry players (in terms of number of patents filed / granted), and current intellectual property-related benchmarks and valuation.
  • A detailed publication analysis of more than 200 peer-reviewed, scientific articles that have been published since 2014, highlighting the research focus within the industry. It also highlights the key trends observed across the publications, including information on innovative technologies, potential application areas, target disease indications, type of cell, and analysis based on various relevant parameters, such as year of publication, and most popular journals (in terms of number of articles published in the given time period) within this domain. 
  • An analysis of the partnerships that have been established in the domain, in the period 2014-Q1 2019, covering R&D collaborations, licensing agreements, distribution agreements, mergers / acquisitions, asset purchase agreements, product development agreements, product utilization agreements, and other relevant deals.
  • An analysis of the investments made at various stages of development, such as seed financing, venture capital financing, debt financing, grants / awards, capital raised from IPOs and subsequent offerings, by companies that are engaged in this field.
  • An analysis to estimate the likely demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in different global regions for the period 2019-2030.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the novel cell sorting and separation market. Based on multiple parameters, such as potential application areas, likely adoption rate and expected pricing, we have provided an informed estimate on the likely evolution of the market, over the period 2019-2030. In addition, we have provided the likely distribution of the current and forecasted opportunity across [A] potential application areas (research studies, clinical diagnostics, cell-based therapeutics, and other applications), [B] end users (academic institutes, clinical testing labs, hospitals, and commercial organizations), [C] type of offering (cell sorters, and consumables and isolation kits), [D] cell sorting technology (buoyancy-activated, magnetophoretics, microfluidics, optoelectronics, and other advanced technologies), [E] type of cell (adult stem cells, CAR-T cells, circulating fetal cells, circulating tumor cells, dendritic cells, embryonic stem cells, insect cells, induced pluripotent stem cells, microbial cells, sperm cells, TCR cells, TILs, and tumor cells / cancer cells), [F] size of cell (< 5 µm, 5-10 µm, 10-15 µm, 15-25 µm, and > 25 µm), and [G] key geographical regions (North America, Europe and Asia-Pacific). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry’s evolution.

The opinions and insights presented in this study were also influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of organization names):

  • John Younger (Co-founder and Chief Technology Officer, Akadeum Life Sciences)
  • Sean Hart (Chief Executive Officer and Chief Scientific Officer, LumaCyte)
  • Soohee Cho (Product Manager, Namocell)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Contents

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of novel cell sorting and separation market in the mid-long term.

Chapter 3 is an introductory chapter that presents a general overview of cell sorting and separation, including a brief history of development, and information on the basic components and principle of operation of a cell sorter. Further, it features a detailed discussion on conventional cell separation techniques and the various challenges associated with their use across different application areas. The chapter also includes detailed sections on the novel cell sorting and separation technologies (such as acoustophoresis, buoyancy-activated, dielectrophoresis, magnetic levitation, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), highlighting their advantages and challenges. Further, it features a discussion on the key growth drivers and roadblocks related to modern cell sorting technologies, as well as upcoming trends that the field is expected to witness in the coming years.

Chapter 4 includes information on more than 200 innovative cell sorters, cell isolation kits, and affiliated consumables and reagents, along with details on their respective specifications (such as size, weight, cell flow rate, cell sort rate, cell analysis rate, cell purity and viability, process time, and operating temperature and pressure), cell sorting technology (acoustophoresis, buoyancy-activated, dielectrophoresis, magnetic levitation, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), type of cell (animal cells, cancer cells, microbial cells, red blood cells / platelets, stem cells, and others), cell separation approach (positive selection, negative selection and depletion), basis for separation (cell morphology and physiology, cell size and density, surface biomarkers, surface charge and adhesion, and others), and end use / application (research studies, biomedical diagnostics, biological therapy-related process operations, and cell-based therapeutics). The chapter also highlights the contributions of various companies engaged in this domain, presenting detailed analyses, based on their year of establishment, size of employee base, geographical presence, and type of offering.

Chapter 5 features an insightful competitiveness analysis of the companies engaged in novel cell sorting and separation domain, based on various parameters, such as number of products offered, number of target cells, end use(s) / application(s), and key product specification(s). In the chapter, stakeholder entities have been plotted on a 2X2 matrix, featuring a company’s Supplier Power (based on size of employee base and experience in this segment of the industry) and Company Competitiveness as the two axes.

Chapter 6 includes elaborate profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are offering novel cell sorters / sorting technologies; each profile features an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.

Chapter 7 includes detailed profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are offering novel consumables and cell isolation kits; each profile features an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.

Chapter 8 provides an in-depth patent analysis to provide an overview of how the industry is evolving from the R&D perspective. For this analysis, we considered those patents that have been filed / granted related to novel cell sorting and separation technologies, since 2014. The analysis also highlights the key trends associated with these patents, across patent type, regional applicability, CPC classification, emerging focus areas, leading industry players (in terms of number of patents filed / granted), and current intellectual property-related benchmarks and valuation.

Chapter 9 presents a detailed publication analysis of more than 200 peer-reviewed, scientific articles that have been published since 2014, highlighting the research focus within the industry. It also highlights the key trends observed across the publications, including information on innovative technologies, potential application areas, target disease indications, type of cell, and analyses based on various relevant parameters, such as year of publication, and most popular journals (in terms of number of articles published in the given time period) within this domain. 

Chapter 10 features an elaborate analysis and discussion of partnerships / collaborations that have been established in this domain in the period 2014-Q1 2019. It includes a brief description of various types of partnership models (such as R&D collaborations, licensing agreements, distribution agreements, mergers / acquisitions, asset purchase agreements, product development agreements, product utilization agreements, and others) that have been employed by stakeholders within this domain. It also consists of a schematic representation showcasing the players that have established the maximum number of alliances related to novel cell sorting and separation technologies. Furthermore, we have provided a world map representation of all the deals inked in this field, highlighting those that have been established within and across different continents.

Chapter 11 provides information on funding instances and investments that have been made within the novel cell sorting and separation domain. The chapter includes details on various types of investments (such as seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings) received by companies in the period 2014-Q1 2019, highlighting the growing interest of the venture capital community and other strategic investors in this domain.

Chapter 12 provides an overview of the demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in the contemporary market. In order to estimate the aforementioned demand, we considered the number of ongoing / completed research studies, diagnostic tests and cell-based therapies under development across different geographies. We also estimated the likely adoption of such products and solutions across key application areas, over the period 2019-2030.

Chapter 13 features a comprehensive market forecast, highlighting the future potential of novel cell sorting and separation market till 2030, based on multiple parameters, such as potential application areas, likely adoption rate and expected pricing. In addition, we estimated the likely distribution of the current and forecasted opportunity across [A] potential application areas (research studies, clinical diagnostics, cell-based therapeutics, and other applications), [B] end users (academic institutes, clinical testing labs, hospitals, and commercial organizations), [C] type of offering (cell sorters, and consumables and isolation kits), [D] cell sorting technology (buoyancy-activated, magnetophoretics, microfluidics, optoelectronics, and other advanced technologies), [E] type of cell (adult stem cells, CAR-T cells, circulating fetal cells, circulating tumor cells, dendritic cells, embryonic stem cells, insect cells, induced pluripotent stem cells, microbial cells, sperm cells, TCR cells, TILs, and tumor cells / cancer cells), [F] size of cell (< 5 µm, 5-10 µm, 10-15 µm, 15-25 µm, and > 25 µm), and [G] key geographical regions (North America, Europe and Asia-Pacific). We adopted a bottom up approach, backed by robust data and credible inputs from primary research, to estimate the likely size of the market, both in terms of value (USD billion) and volume (number of products).

Chapter 14 is a collection of executive insights of the discussions that were held with various key stakeholders in this market. The chapter provides a brief overview of the companies and details of interviews held with John Younger (Co-founder and Chief Technology Officer, Akadeum Life Sciences), Sean Hart (Chief Executive Officer and Chief Scientific Officer, LumaCyte), and Soohee Cho (Product Manager, Namocell).

Chapter 15 is a summary of the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 16 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 17 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
 
2. EXECUTIVE SUMMARY
 
3. INTRODUCTION
3.1. Context and Background
3.2. Introduction to Cell Sorting and Separation
3.2.1. Historical Overview
3.2.2. Basic Components and Principle of Operation
3.2.3. Cellular Characteristics Considered for Cell Sorting and Separation
3.2.3.1. Cell Size and Density
3.2.3.2. Hydrodynamic Properties
3.2.3.3. Polarizability, Electrical Impedance and Magnetic Susceptibility
3.2.3.4. Surface Charge and Adhesion
 
3.2.4. Conventional Cell Sorting and Separation Methods
3.2.4.1. Adhesion-based Sorting
3.2.4.2. Density Gradient Centrifugation Sorting
3.2.4.3. Fluorescence-activated Sorting
3.2.4.4. Magnetic-activated Sorting
3.2.4.5. Membrane Filtration Sorting
3.2.5. Limitations of Conventional Cell Sorting and Separation Methods
 
3.3. Novel Cell Sorting and Separation Technologies
3.3.1. Buoyancy-activated Sorting
3.3.2. Microfluidics-based Sorting
3.3.2.1. Microfluidics-based Active Sorting Technologies
3.3.2.1.1. Acoustic Sorting
3.3.2.1.2. Aqueous Two-Phase Sorting
3.3.2.1.3. Electrophoretic Sorting
3.3.2.1.4. Magnetic Levitation-based Sorting
3.3.2.1.5. Optoelectronics-based Sorting
 
3.3.2.2. Microfluidics-based Passive Sorting Technologies
3.3.2.2.1. Biomimetic Sorting
3.3.2.2.2. Deterministic Lateral Displacement Sorting
3.3.2.2.3. Field Flow Fractionation Sorting
3.3.2.2.4. Gravity and Sedimentation Sorting
3.3.2.2.5. Hydrodynamic Sorting
3.3.2.2.6. Inertia-based Sorting
3.3.2.2.7. Microfiltration Sorting
3.3.2.2.8. Microstructures-based Sorting
 
3.3.3. Other Types of Cell Sorting and Separation Technologies
3.3.3.1. Density Difference Amplification-based Sorting
3.3.3.2. SpheriTech Purification and Sorting
3.3.3.3. Traceless Affinity-based Sorting
 
3.4. Key Applications of Novel Cell Sorting and Separation Technologies
3.4.1. Clinical Research
3.4.2. Biomedical Diagnostics
3.4.3. Cell-based Therapeutics
 
3.5. Growth Drivers and Roadblocks
3.6. Recent Developments and Upcoming Trends
 
4. CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Novel Cell Sorting Products and Solutions: Overall Market Landscape
4.2.1. Analysis by Type of Product
4.2.2. Analysis by Basis for Separation
4.2.3. Analysis by Type of Technology
4.2.4. Analysis by Cell Separation Approach
4.2.5. Analysis by Type of Cell
 
4.3. Novel Cell Sorting Products and Solutions: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Location of Headquarters
4.3.3. Analysis by Size of Company
4.3.4. Analysis by Type of Offering
4.3.5. Analysis by End Use / Application
4.3.6. Leading Developers: Analysis by Number of Products
4.3.7. Grid Analysis by Company Size, Type of Offering and End Use / Application
 
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Parameters
5.4. Novel Cell Sorting Products and Solutions Providers: Company Competitiveness Analysis
5.4.1. Small-sized Companies
5.4.2. Mid-sized Companies
5.4.3. Large Companies
 
6. PROFILES: COMPANIES OFFERING NOVEL CELL SORTERS / SORTING TECHNOLOGIES
6.1. Chapter Overview
6.2. NanoCellect Biomedical
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. WOLF® Cell Sorter, N1® Single Cell Dispenser: Product Description
6.2.4. Recent Developments and Future Outlook
 
6.3. Innovative Biochips
6.3.1. Company Overview
6.3.2 Financial Information
6.3.3. SMART ALIQUOTOR, SMART ALIQUOTOR COMPACT EDITION, SMART ALIQUOTOR EXTENDED EDITION: Product Description
6.3.4. Recent Developments and Future Outlook
 
6.4. Cesca Therapeutics
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. AUTOXPRESS®, CAR-TXPRESS™, CELLXPRESS™: Product Description
6.4.4. Recent Developments and Future Outlook
 
6.5. Fluidigm
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. C1™ System: Product Description
6.5.4. Recent Developments and Future Outlook
 
6.6. LumaCyte
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Radiance™: Product Description
6.6.4. Recent Developments and Future Outlook
 
6.7. Union Biometrica
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. COPAS™ FP, BioSorter®: Product Description
6.7.4. Recent Developments and Future Outlook
 
6.8. LevitasBio
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. LeviCell System: Product Description
6.8.4. Recent Developments and Future Outlook
 
6.9. RareCyte®
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. AccuCyte® Sample Preparation System: Product Description
6.9.4. Recent Developments and Future Outlook
 
6.10. Cytonome
6.10.1. Cytonome Viva™, Cytonome Hydris™, Cytonome GigaSort™: Product Description
6.10.2. Recent Developments and Future Outlook
 
6.11. Namocell
6.11.1. Namo™ Single Cell Dispenser, Hana™ Single Cell Dispenser: Product Description
6.11.2. Recent Developments and Future Outlook
 
7. PROFILES: COMPANIES OFFERING NOVEL CONSUMABLES AND ISOLATION KITS
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Product Portfolio
7.2.4. Recent Developments and Future Outlook
 
7.3. Akadeum Life Sciences
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Product Portfolio
7.3.4. Recent Developments and Future Outlook
 
7.4. QIAGEN
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Product Portfolio
7.4.4. Recent Developments and Future Outlook
 
7.5. RareCyte®
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Product Portfolio
7.5.4. Recent Developments and Future Outlook
 
7.6. ScreenCell
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook
 
8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Novel Cell Sorting Products and Solutions: Patent Analysis
8.3.1. Analysis by Publication Year
8.3.2. Analysis by Geographical Location
8.3.3 Analysis by CPC Symbols
8.3.4. Emerging Focus Areas
8.3.5. Leading Players: Analysis by Number of Patents
 
8.4. Novel Cell Sorting Products and Solutions: Patent Benchmarking Analysis (Industry Players)
8.4.1. Analysis by Patent Characteristics
8.4.2. Analysis by Geographical Location
 
8.5. Novel Cell Sorting Products and Solutions: Patent Valuation Analysis
8.6. Leading Patents: Analysis by Number of Citations
 
9. PUBLICATION ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Novel Cell Sorting Products and Solutions: Publication Analysis
9.3.1. Analysis by Year of Publication
9.3.2. Emerging Focus Areas
9.3.3. Analysis by Cell Sorting Technology
9.3.4. Analysis by Application Area
9.3.5. Analysis by Type of Cell
9.3.6. Analysis by Target Disease Indication
9.3.7. Analysis by Type of Organization Involved
9.3.8. Leading Players: Analysis by Number of Publications
9.3.9. Leading Players: Geographical Analysis by Number of Publications
9.3.10. Key Journals: Analysis by Number of Publications
 
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Novel Cell Sorting Products and Solutions: Recent Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Cell Sorting Technology
10.3.4. Analysis by Type of Partner
10.3.5. Most Active Players: Analysis by Number of Partnerships
10.3.6. Geographical Analysis
10.3.6.1. Most Active Players
10.3.6.2. Intercontinental and Intracontinental Agreements
 
11. FUNDING AND INVESTMENT ANALYSIS
11.1. Chapter Overview
11.2. Types of Funding
11.3. Novel Cell Sorting Products and Solutions: Recent Funding Instances
11.3.1. Analysis by Number of Funding Instances
11.3.2. Analysis by Amount Invested
11.3.3. Analysis by Type of Funding
11.3.4. Analysis by Number of Funding Instances and Amount Invested across Different Cell Sorting Technologies
11.3.5. Most Active Players: Analysis by Number of Funding Instances
11.3.6. Most Active Players: Analysis by Amount Invested
11.3.7. Most Active Investors: Analysis by Number of Instances
11.3.8. Geographical Analysis by Amount Invested
11.4. Concluding Remarks
 
12. DEMAND ANALYSIS
12.1. Chapter Overview
12.2 Key Assumptions and Methodology
 
12.3. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030
12.3.1. Global Demand for Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
12.3.1.1. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030
12.3.1.2. Global Demand for Novel Cell Sorting Products and Solutions for Circulating Tumor Cell Detection, 2019-2030
12.3.1.3. Global Demand for Novel Cell Sorting Products and Solutions for In vitro Fertilization, 2019-2030
12.3.1.4. Global Demand for Novel Cell Sorting Products and Solutions for Non-Invasive Prenatal Diagnostics, 2019-2030
12.3.1.5. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030
 
12.3.2. Global Demand for Novel Cell Sorting Products and Solutions: Distribution by Geography and End Use / Application
12.3.2.1. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030
12.3.2.1.1. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030
12.3.2.1.2. Demand for Novel Cell Sorting Products and Solutions in North America for Circulating Tumor Cell Detection, 2019-2030
12.3.2.1.3. Demand for Novel Cell Sorting Products and Solutions in North America for In vitro Fertilization, 2019-2030
12.3.2.1.4. Demand for Novel Cell Sorting Products and Solutions in North America for Non-Invasive Prenatal Diagnosis, 2019-2030
12.3.2.1.5. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030
 
12.3.2.2. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030
12.3.2.2.1. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030
12.3.2.2.2. Demand for Novel Cell Sorting Products and Solutions in Europe for Circulating Tumor Cell Detection, 2019-2030
12.3.2.2.3. Demand for Novel Cell Sorting Products and Solutions in Europe for In vitro Fertilization, 2019-2030
12.3.2.2.4. Demand for Novel Cell Sorting Products and Solutions in Europe for Non-Invasive Prenatal Diagnosis, 2019-2030
12.3.2.2.5. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030
 
12.3.2.3. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030
12.3.2.3.1. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030
12.3.2.3.2. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Circulating Tumor Cell Detection, 2019-2030
12.3.2.3.3. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for In vitro Fertilization, 2019-2030
12.3.2.3.4. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Non-Invasive Prenatal Diagnosis, 2019-2030
12.3.2.3.5. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030
 
13. MARKET FORECAST
13.1. Chapter Overview
13.2. Key Assumptions and Forecast Methodology
 
13.3. Overall Novel Cell Sorting Products and Solutions Market
13.3.1. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (By Value)
13.3.2 Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (By Volume)
 
13.4. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering
13.4.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (By Value)
13.4.1.1. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (By Value)
13.4.1.2. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (By Value)
 
13.4.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (By Volume)
13.4.2.1. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (By Volume)
13.4.2.2. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (By Volume)
 
13.5. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application
13.5.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (By Value)
13.5.1.1. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (By Value)
13.5.1.2. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.5.1.3. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (By Value)
13.5.1.4. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.5.1.5. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (By Value)
 
13.5.2. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (By Volume)
13.5.2.1. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (By Volume)
13.5.2.2. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.5.2.3. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (By Volume)
13.5.2.4. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.5.2.5. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (By Volume)
 
13.6. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology
13.6.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (By Value)
13.6.1.1. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (By Value)
13.6.1.2. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (By Value)
13.6.1.3. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (By Value)
13.6.1.4. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (By Value)
13.6.1.5. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (By Value)
 
13.6.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (By Volume)
13.6.2.1. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (By Volume)
13.6.2.2. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (By Volume)
13.6.2.3. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (By Volume)
13.6.2.4. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (By Volume)
13.6.2.5. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (By Volume)
 
13.7. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell
13.7.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (By Value)
13.7.1.1. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (By Value)
13.7.1.2. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (By Value)
13.7.1.3. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (By Value)
13.7.1.4. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (By Value)
13.7.1.5. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (By Value)
13.7.1.6. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (By Value)
 
13.7.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (By Volume)
13.7.2.1. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (By Volume)
13.7.2.2. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (By Volume)
13.7.2.3. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (By Volume)
13.7.2.4. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (By Volume)
13.7.2.5. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (By Volume)
13.7.2.6. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (By Volume)
 
13.8. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography
13.8.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (By Value)
13.8.1.1. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (By Value)
13.8.1.2. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (By Value)
13.8.1.3 Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (By Value)
 
13.8.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (By Volume)
13.8.2.1. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (By Volume)
13.8.2.2. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (By Volume)
13.8.2.3. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (By Volume)
 
13.9. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application Cell Sorting Technology and Type of Offering
13.9.1. Overall Novel Cell Sorting Products and Solutions Market for Research Studies: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.1.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.1.1. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
 
13.9.1.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.2.1. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
 
13.9.1.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.3.1. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.3.2. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
 
13.9.1.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.4.1. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
 
13.9.1.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.5.1. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
 
13.9.2. Overall Novel Cell Sorting Products and Solutions Market for Research Studies: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.2.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.1.1. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
 
13.9.2.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.2.1. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
 
13.9.2.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.3.1. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.3.2. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
 
13.9.2.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.4.1. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
 
13.9.2.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.5.1. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
 
13.9.3. Overall Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.3.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.1.1. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
 
13.9.3.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.2.1. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
 
13.9.3.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.3.1. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.3.2. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
 
13.9.3.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.4.1. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
 
13.9.3.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.5.1. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
 
13.9.4. Overall Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.4.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.1.1. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
 
13.9.4.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.2.1. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
 
13.9.4.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.3.1. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.3.2. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
 
13.9.4.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.4.1. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
 
13.9.4.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.5.1. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
 
13.9.5. Overall Novel Cell Sorting Products and Solutions Market for In vitro Fertilization: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.5.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.1.1. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.1.2. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
 
13.9.5.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.2.1. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
 
13.9.5.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.3.1. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.3.2. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
 
13.9.5.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.4.1. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.4.2. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
 
13.9.5.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.5.1. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
 
13.9.6. Overall Novel Cell Sorting Products and Solutions Market for In vitro Fertilization: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.6.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.1.1. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.1.2. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
 
13.9.6.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.2.1. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
 
13.9.6.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.3.1. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.3.2. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
 
13.9.6.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.4.1. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.4.2. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
 
13.9.6.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.5.1. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
 
13.9.7. Overall Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.7.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.1.1. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
 
13.9.7.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.2.1. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
 
13.9.7.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.3.1. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.3.2. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
 
13.9.7.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.4.1. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
 
13.9.7.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.5.1. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
 
13.9.8. Overall Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.8.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.1.1. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
 
13.9.8.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.2.1. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
 
13.9.8.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.3.1. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.3.2. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
 
13.9.8.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.4.1. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
 
13.9.8.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.5.1. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
 
13.9.9. Overall Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.9.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.1.1. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
 
13.9.9.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.2.1. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
 
13.9.9.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.3.1. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.3.2. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
 
13.9.9.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.4.1. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
 
13.9.9.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.5.1. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
 
13.9.10. Overall Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.10.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.1.1. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
 
13.9.10.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.2.1. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
 
13.9.10.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.3.1. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.3.2. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
 
13.9.10.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.4.1. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
 
13.9.10.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.5.1. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
 
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Akadeum Life Sciences
14.2.1. Company Snapshot
14.2.2. Interview Transcript: John Younger, Co-founder and Chief Technology Officer
 
14.3. LumaCyte
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Sean Hart, Chief Executive Officer and Chief Scientific Officer
 
14.4. Namocell
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Soohee Cho, Product Manager
 
15. CONCLUDING REMARKS
15.1. Chapter Overview
15.2. Key Takeaways
 
16. APPENDIX 1: TABULATED DATA
 
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

Figure 3.1. Basic Components of a Cell Sorter
Figure 3.2. Limitations of Conventional Cell Sorting and Separation Methods
Figure 3.3. Classification of Novel Cell Sorting and Separation Technologies
Figure 3.4. Advantages and Challenges of Buoyancy-activated Cell Sorting
Figure 3.5. Advantages and Challenges of Microfluidics-based Cell Sorting
Figure 3.6. Key Applications of Novel Cell Sorting and Separation Technologies
Figure 3.7. Growth Drivers and Roadblocks to Novel Cell Sorting and Separation Technologies
Figure 3.8. Recent Developments and Upcoming Trends Related to Novel Cell Sorting and Separation Technologies
Figure 4.1. Novel Cell Sorting Products and Solutions: Distribution by Type of Product
Figure 4.2. Novel Cell Sorting Products and Solutions: Distribution by Basis for Separation
Figure 4.3. Novel Cell Sorting Products and Solutions: Distribution by Type of Cell Sorting Technology
Figure 4.4. Novel Cell Sorting Products and Solutions: Logo Landscape of Developers by Type of Cell Sorting Technology
Figure 4.5. Novel Cell Sorting Products and Solutions: Distribution by Cell Separation Approach
Figure 4.6. Novel Cell Sorting Products and Solutions: Distribution by Type of Cell
Figure 4.7. Popular Cell Types: Distribution by Number of Products
Figure 4.8. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Year of Establishment
Figure 4.9. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Geographical Location
Figure 4.10. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size
Figure 4.11. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Type of Offering
Figure 4.12. Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
Figure 4.13. Leading Developers: Distribution by Number of Products
Figure 4.14. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size, Type of Offering and End Use / Application
Figure 5.1. Competitiveness Analysis of Small-sized Novel Cell Sorting Products and Solutions Providers
Figure 5.2. Competitiveness Analysis of Mid-sized Novel Cell Sorting Products and Solutions Providers
Figure 5.3. Competitiveness Analysis of Large Novel Cell Sorting Products and Solutions Providers
Figure 8.1. Patent Analysis: Distribution by Type
Figure 8.2. Patent Analysis: Cumulative Year-wise Trend, 2014-2018
Figure 8.3. Patent Analysis: Distribution by Geographical Location
Figure 8.4. Patent Analysis: Distribution by CPC Symbols (Top 20)
Figure 8.5. Patent Analysis: Emerging Focus Areas
Figure 8.6. Most Active Industry Players: Distribution by Number of Patents
Figure 8.7. Most Active Non-Industry Players: Distribution by Number of Patents
Figure 8.8. Patent Analysis: Benchmarking by Patent Characteristics
Figure 8.9. Patent Analysis: Benchmarking by Number of Patents Published across Different Geographies
Figure 8.10. Patent Analysis: Benchmarking by Number of International Patents
Figure 8.11. Patent Analysis: Distribution by Patent Age, 2014-2018
Figure 8.12. Patent Analysis: Distribution by Geography and Year of Publication, 2014-2018
Figure 8.13. Patent Analysis: Distribution by Relative Valuation
Figure 9.1. Publication Analysis: Cumulative Year-wise Trend, 2014-2018
Figure 9.2. Publication Analysis: Emerging Focus Areas
Figure 9.3. Publication Analysis: Distribution by Cell Sorting Technology
Figure 9.4. Publication Analysis: Distribution by End Use / Application Area
Figure 9.5. Publication Analysis: Distribution by Type of Cell
Figure 9.6. Publication Analysis: Distribution by Target Disease Indication
Figure 9.7. Publication Analysis: Distribution by Type of Organization Involved
Figure 9.8. Most Active Players: Distribution by Number of Publications
Figure 9.9. Most Active Players: Geographical Distribution by Number of Publications
Figure 9.10. Key Journals: Distribution by Number of Publications
Figure 10.1. Partnerships and Collaborations: Cumulative Year-wise Trend, 2014-Q1 2019
Figure 10.2. Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3. Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Figure 10.4. Partnerships and Collaborations: Distribution by Cell Sorting Technology
Figure 10.5. Partnerships and Collaborations: Year-wise Trend by Cell Sorting Technology
Figure 10.6. Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.7. Most Active Players: Distribution by Number of Partnerships
Figure 10.8. Most Active Players: Geographical Distribution by Number of Partnerships
Figure 10.9. Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 11.1. Funding and Investments: Distribution of Industry Players by Year of Establishment and Type of Funding, 2014-Q1 2019
Figure 11.2. Funding and Investments: Distribution of Amount Invested by Focus Area and Type of Funding, 2014-Q1 2019
Figure 11.3. Funding and Investments: Cumulative Year-wise Trend, 2014-Q1 2019
Figure 11.4. Funding and Investments: Cumulative Amount Invested by Year, 2014-Q1 2019 (USD Million)
Figure 11.5. Funding and Investments: Distribution by Type of Funding
Figure 11.6. Funding and Investments: Distribution by Amount Invested and Type of Funding (USD Million)
Figure 11.7. Funding and Investments: Summary of Investments, 2014-Q1 2019 (USD Million)
Figure 11.8. Popular Cell Sorting Technologies: Distribution by Number of Funding Instances
Figure 11.9. Popular Cell Sorting Technologies: Distribution by Amount Invested (USD Million)
Figure 11.10. Funding and Investments: Year-wise Trend of Amount Invested across Different Cell Sorting Technologies, 2014-Q1 2019 (USD Million)
Figure 11.11. Most Active Players: Distribution by Number of Instances
Figure 11.12. Most Active Players: Distribution by Capital Amount Raised (USD Million)
Figure 11.13. Most Active Investors: Distribution by Number of Instances
Figure 11.14. Funding and Investments: Geographical Distribution by Amount Invested (USD Million)
Figure 11.15. Funding and Investment Summary
Figure 12.1. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030 (Million Units)
Figure 12.2. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 12.3. Global Demand for Novel Cell Sorting Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 12.4. Global Demand for Novel Cell Sorting Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 12.5. Global Demand for Novel Cell Sorting Products and Solutions for Non-Invasive Prenatal Diagnostics, 2019-2030 (Million Units)
Figure 12.6. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 12.7. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030 (Million Units)
Figure 12.8. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030 (Million Units)
Figure 12.9. Demand for Novel Cell Sorting Products and Solutions in North America for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 12.10. Demand for Novel Cell Sorting Products and Solutions in North America for In vitro Fertilization, 2019-2030 (Million Units)
Figure 12.11. Demand for Novel Cell Sorting Products and Solutions in North America for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 12.12. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 12.13. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030 (Million Units)
Figure 12.14. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030 (Million Units)
Figure 12.15. Demand for Novel Cell Sorting Products and Solutions in Europe for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 12.16. Demand for Novel Cell Sorting Products and Solutions in Europe for In vitro Fertilization, 2019-2030 (Million Units)
Figure 12.17. Demand for Novel Cell Sorting Products and Solutions in Europe for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 12.18. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 12.19. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030 (Million Units)
Figure 12.20. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030 (Million Units)
Figure 12.21. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 12.22. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for In vitro Fertilization, 2019-2030 (Million Units)
Figure 12.23. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 12.24. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 13.1. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (USD Million)
Figure 13.2. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (Million Units)
Figure 13.3. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (USD Million)
Figure 13.4. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (USD Million)
Figure 13.5. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (USD Million)
Figure 13.6. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (Million Units)
Figure 13.7. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (Million Units)
Figure 13.8. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (Million Units)
Figure 13.9. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (USD Million)
Figure 13.10. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (USD Million)
Figure 13.11. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.12. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 13.13. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 13.14. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.15. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (Million Units)
Figure 13.16. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (Million Units)
Figure 13.17. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 13.18. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 13.19. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 13.20. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 13.21. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (USD Million)
Figure 13.22. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (USD Million)
Figure 13.23. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (USD Million)
Figure 13.24. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (USD Million)
Figure 13.25. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (USD Million)
Figure 13.26. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (USD Million)
Figure 13.27. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (Million Units)
Figure 13.28. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (Million Units)
Figure 13.29. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (Million Units)
Figure 13.30. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (Million Units)
Figure 13.31. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (Million Units)
Figure 13.32. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (Million Units)
Figure 13.33. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (USD Million)
Figure 13.34. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (USD Million)
Figure 13.35. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (USD Million)
Figure 13.36. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (USD Million)
Figure 13.37. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (USD Million)
Figure 13.38. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (USD Million)
Figure 13.39. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (USD Million)
Figure 13.40. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (Million Units)
Figure 13.41. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (Million Units)
Figure 13.42. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (Million Units)
Figure 13.43. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (Million Units)
Figure 13.44. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (Million Units)
Figure 13.45. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (Million Units)
Figure 13.46. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (Million Units)
Figure 13.47. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (USD Million)
Figure 13.48. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (USD Million)
Figure 13.49. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (USD Million)
Figure 13.50. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (USD Million)
Figure 13.51. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (Million Units)
Figure 13.52. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (Million Units)
Figure 13.53. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (Million Units)
Figure 13.54. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (Million Units)
Figure 13.55. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.56. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.57. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.58. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.59. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.60. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.61. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.62. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.63. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.64. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.65. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.66. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.67. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.68. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.69. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.70. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.71. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.72. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.73. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.74. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.75. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.76. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.77. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.78. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.79. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.80. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.81. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.82. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.83. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.84. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.85. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.86. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.87. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.88. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.89. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.90. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.91. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.92. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.93. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.94. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.95. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.96. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.97. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.98. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.99. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 14.100. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.101. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.102. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.103. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.104. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.105. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.106. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.107. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.108. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.109. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.110. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.111. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.112. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.113. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.114. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.115. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.116. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.117. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.118. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.119. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.120. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.121. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.122. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.123. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.124. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.125. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.126. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.127. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.128. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.129. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.130. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.131. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.132. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.133. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.134. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.135. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.136. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.137. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.138. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.139. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.140. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.141. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.142. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.143. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.144. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.145. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.146. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.147. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.148. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.149. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.150. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.151. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.152. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.153. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.154. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.155. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.156. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.157. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.158. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.159. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.160. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.161. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.162. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.163. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.164. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.165. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.166. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.167. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.168. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.169. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.170. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.171. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.172. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.173. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.174. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.175. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.176. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.177. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.178. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.179. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.180. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.181. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.182. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.183. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.184. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.185. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.186. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.187. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.188. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.189. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.190. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.191. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.192. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.193. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.194. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.195. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.196. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.197. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.198. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.199. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.200. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.201. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.202. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.203. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.204. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)

List of Tables

Table 3.1. Conventional Flow Cytometers
Table 3.2. Microfluidics-based Cell Sorting Technologies
Table 4.1. Novel Cell Sorting Products and Solutions: Information on Type of Product, Cell Sorting Technology and Type of Cell
Table 4.2. Novel Cell Sorting Products and Solutions: Information on Cell Separation Approach, Basis for Separation and End Use / Application
Table 4.3. Novel Cell Sorting Products and Solutions: Information on Key Specifications
Table 4.4. Novel Cell Sorting Products and Solutions: Developer Overview
Table 5.1. Competitiveness Analysis of Small-sized Novel Cell Sorting Products and Solutions Providers
Table 5.2. Competitiveness Analysis of Mid-sized Novel Cell Sorting Products and Solutions Providers
Table 5.3. Competitiveness Analysis of Large-sized Novel Cell Sorting Products and Solutions Providers
Table 6.1. NanoCellect Biomedical: Key Highlights
Table 6.2. NanoCellect Biomedical: Funding Instances
Table 6.3. NanoCellect Biomedical: Key Characteristics of WOLF® Cell Sorter and N1® Single Cell Dispenser
Table 6.4. NanoCellect Biomedical: Recent Developments and Future Outlook
Table 6.5. Innovative Biochips: Key Highlights
Table 6.6. Innovative Biochips: Funding Instances
Table 6.7. Innovative Biochips: Key Characteristics of SMART ALIQUOTOR, SMART ALIQUOTOR COMPACT EDITION and SMART ALIQUOTOR EXTENDED EDITION
Table 6.8. Recent Developments and Future Outlook
Table 6.9. Cesca Therapeutics: Key Highlights
Table 6.10. Cesca Therapeutics: Funding Instances
Table 6.11. Cesca Therapeutics: Key Characteristics of AUTOXPRESS®, CAR-TXPRESS™ and CELLXPRESS™
Table 6.12. Recent Developments and Future Outlook
Table 6.13. Fluidigm: Key Highlights
Table 6.14. Fluidigm: Funding Instances
Table 6.15. Fluidigm: Key Characteristics of C1™ System
Table 6.16. Fluidigm: Recent Developments and Future Outlook
Table 6.17. LumaCyte: Key Highlights
Table 6.18. LumaCyte: Funding Instances
Table 6.19. LumaCyte: Key Characteristics of Radiance™
Table 6.20. LumaCyte: Recent Developments and Future Outlook
Table 6.21. Union Biometrica: Key Highlights
Table 6.22. Union Biometrica: Key Characteristics of COPAS™ FP and BioSorter®
Table 6.23. Union Biometrica: Recent Developments and Future Outlook
Table 6.24. LevitasBio: Key Highlights
Table 6.25. LevitasBio: Funding Instances
Table 6.26. LevitasBio: Key Characteristics of LeviCell System
Table 6.27. LevitasBio: Recent Developments and Future Outlook
Table 6.28. RareCyte®: Key Highlights
Table 6.29. RareCyte®: Funding Instances
Table 6.30. RareCyte®: Key Characteristics of AccuCyte® Sample Preparation System
Table 6.31. RareCyte®: Recent Developments and Future Outlook
Table 6.32. Cytonome: Key Highlights
Table 6.33. Cytonome: Key Characteristics of Cytonome Viva™, Cytonome Hydris™, Cytonome GigaSort™
Table 6.34. Cytonome: Recent Developments and Future Outlook
Table 6.35. Namocell: Key Highlights
Table 6.36. Namocell: Funding Instances
Table 6.37. Namocell: Key Characteristics of Namo™ Single Cell Dispenser and Hana™ Single Cell Dispenser
Table 6.38. Namocell: Recent Developments and Future Outlook
Table 7.1. STEMCELL Technologies: Key Highlights
Table 7.2. STEMCELL Technologies: Funding Instances
Table 7.3. STEMCELL Technologies: Product Portfolio
Table 7.4. STEMCELL Technologies: Recent Developments and Future Outlook
Table 7.5. Akadeum Life Sciences: Key Highlights
Table 7.6. Akadeum Life Sciences: Funding Instances
Table 7.7. Akadeum Life Sciences: Product Portfolio
Table 7.8. Akadeum Life Sciences: Recent Developments and Future Outlook
Table 7.3. QIAGEN: Key Highlights
Table 7.10. QIAGEN: Funding Instances
Table 7.11. QIAGEN: Product Portfolio
Table 7.12. QIAGEN: Recent Developments and Future Outlook
Table 7.13. ScreenCell: Key Highlights
Table 7.14. ScreenCell: Product Portfolio
Table 7.15. ScreenCell: Recent Developments and Future Outlook
Table 7.16. RareCyte®: Product Portfolio
Table 8.1. Patent Analysis: CPC Symbol Definitions
Table 8.2. Patent Analysis: Most Popular CPC Symbols
Table 8.3. Patent Analysis: List of Top CPC Symbols
Table 8.4. Novel Cell Sorting Products and Solutions: Summary of Patent Benchmarking Analysis
Table 8.5. Novel Cell Sorting Products and Solutions: Categorizations based on Weighted Valuation Scores
Table 8.6. Leading Patents: Distribution by Relative Valuation
Table 8.7. Leading Patents: Distribution by Number of Citations
Table 10.1. Novel Cell Sorting Products and Solutions: List of Partnerships, 2014-Q1 2019
Table 10.2. Most Active Players: Geographical Distribution by Number of Partnerships
Table 11.1. Novel Cell Sorting Products and Solutions: List of Funding Instances, 2014-Q1 2019
Table 11.2. Novel Cell Sorting Products and Solutions: Summary of Investments
Table 14.1. Akadeum Life Sciences: Key Highlights
Table 14.2. LumaCyte: Key Highlights
Table 14.3. Namocell: Key Highlights
Table 15.1. Novel Cell Sorting Products and Solutions: Key Takeaways
Table 16.1. Novel Cell Sorting Products and Solutions: Distribution by Type of Product
Table 16.2. Novel Cell Sorting Products and Solutions: Distribution by Cell Sorting Technology
Table 16.3. Novel Cell Sorting Products and Solutions: Distribution by Type of Cell
Table 16.4. Novel Cell Sorting Products and Solutions: Distribution by Cell Separation Approach
Table 16.5. Novel Cell Sorting Products and Solutions: Distribution by Basis for Separation
Table 16.6. Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
Table 16.7. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Year of Establishment
Table 16.8. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Geographical Location
Table 16.9. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size
Table 16.10. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Type of Offering
Table 16.11. Leading Developers: Distribution by Number of Products
Table 16.12. Competitiveness Analysis of Small-sized Novel Cell Sorting Products and Solutions Providers
Table 16.13. Competitiveness Analysis of Mid-sized Novel Cell Sorting Products and Solutions Providers
Table 16.14. Competitiveness Analysis of Large Novel Cell Sorting Products and Solutions Providers
Table 16.15. Patent Analysis: Distribution by Type
Table 16.16. Patent Analysis: Cumulative Year-wise Trend, 2014-2018
Table 16.17. Patent Analysis: Distribution by Geographical Location
Table 16.18. Patent Analysis: Distribution by CPC Symbols (Top 20)
Table 16.19. Most Active Industry Players: Distribution by Number of Patents
Table 16.20. Most Active Non-Industry Players: Distribution by Number of Patents
Table 16.21. Patent Analysis: Benchmarking by Patent Characteristics
Table 16.22. Patent Analysis: Benchmarking by Number of Patents Published across Different Geographies
Table 16.23. Patent Analysis: Benchmarking by Number of International Patents
Table 16.24. Patent Analysis: Distribution by Patent Age, 2014-2018
Table 16.25. Patent Analysis: Distribution by Geography and Year of Publication, 2014-2018
Table 16.26. Patent Analysis: Distribution by Relative Valuation
Table 16.27. Publication Analysis: Cumulative Year-wise Trend, 2014-2018
Table 16.28. Publication Analysis: Distribution by Cell Sorting Technology
Table 16.29. Publication Analysis: Distribution by End Use / Application Area
Table 16.30. Publication Analysis: Distribution by Type of Cell
Table 16.31. Publication Analysis: Distribution by Target Disease Indication
Table 16.32. Publication Analysis: Distribution by Type of Organization Involved
Table 16.33. Most Active Players: Distribution by Number of Publications
Table 16.34. Most Active Players: Geographical Distribution by Number of Publications
Table 16.35. Key Journals: Distribution by Number of Publications
Table 16.36. Partnerships and Collaborations: Cumulative Year-wise Trend, 2014-Q1 2019
Table 16.37. Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.38. Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Table 16.39. Partnerships and Collaborations: Distribution by Partner’s Focus Area
Table 16.40. Partnerships and Collaborations: Distribution by Cell Sorting Technology
Table 16.41. Partnerships and Collaborations: Year-wise Trend by Cell Sorting Technology
Table 16.42. Most Active Players: Distribution by Number of Partnerships
Table 16.43. Most Active Players: Geographical Distribution by Number of Partnerships
Table 16.44. Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.45. Funding and Investments: Distribution of Industry Players by Year of Establishment and Type of Funding, 2014-Q1 2019
Table 16.46. Funding and Investments: Distribution of Amount Invested by Focus Area and Type of Funding, 2014-Q1 2019
Table 16.47. Funding and Investments: Cumulative Year-wise Trend, 2014-Q1 2019
Table 16.48. Funding and Investments: Cumulative Amount Invested by Year, 2014-Q1 2019 (USD Million)
Table 16.49. Funding and Investments: Distribution by Type of Funding
Table 16.50. Funding and Investments: Distribution by Amount Invested and Type of Funding (USD Million)
Table 16.51. Popular Cell Sorting Technologies: Distribution by Number of Funding Instances
Table 16.52. Popular Cell Sorting Technologies: Distribution by Amount Invested (USD Million)
Table 16.53. Funding and Investments: Year-wise Trend of Amount Invested across Different Cell Sorting Technologies, 2014-Q1 2019 (USD Million)
Table 16.54. Most Active Players: Distribution by Number of Instances
Table 16.55. Most Active Players: Distribution by Capital Amount Raised (USD Million)
Table 16.56. Most Active Investors: Distribution by Number of Instances
Table 16.57. Funding and Investments: Geographical Distribution by Amount Invested (USD Million)
Table 16.58. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030 (Million Units)
Table 16.59. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030 (Million Units)
Table 16.60. Global Demand for Novel Cell Sorting Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Table 16.61. Global Demand for Novel Cell Sorting Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Table 16.62. Global Demand for Novel Cell Sorting Products and Solutions for Non-Invasive Prenatal Diagnostics, 2019-2030 (Million Units)
Table 16.63. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Table 16.64. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030 (Million Units)
Table 16.65. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030 (Million Units)
Table 16.66. Demand for Novel Cell Sorting Products and Solutions in North America for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Table 16.67. Demand for Novel Cell Sorting Products and Solutions in North America for In vitro Fertilization, 2019-2030 (Million Units)
Table 16.68. Demand for Novel Cell Sorting Products and Solutions in North America for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Table 16.69. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030 (Million Units)
Table 16.70. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030 (Million Units)
Table 16.71. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030 (Million Units)
Table 16.72. Demand for Novel Cell Sorting Products and Solutions in Europe for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Table 16.73. Demand for Novel Cell Sorting Products and Solutions in Europe for In vitro Fertilization, 2019-2030 (Million Units)
Table 16.74. Demand for Novel Cell Sorting Products and Solutions in Europe for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Table 16.75. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030 (Million Units)
Table 16.76. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030 (Million Units)
Table 16.77. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030 (Million Units)
Table 16.78. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Table 16.79. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for In vitro Fertilization, 2019-2030 (Million Units)
Table 16.80. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Table 16.81. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030 (Million Units)
Table 16.82. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.83. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.84. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.85. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.86. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.87. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.88. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.89. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.90. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.91. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.92. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.93. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.94. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.95. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.96. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.97. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.98. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.99. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.100. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.101. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.102. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.103. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.104. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.105. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.106. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.107. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.108. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.109. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.110. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.111. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.112. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.113. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.114. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.115. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.116. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.117. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.118. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.119. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.120. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.121. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.122. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.123. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.124. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.125. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.126. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.127. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.128. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.129. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.130. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.131. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.132. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.133. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.134. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.135. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.136. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.137. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.138. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.139. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.140. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.141. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.142. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.143. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.144. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.145. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.146. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.147. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.148. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.149. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.150. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.151. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.152. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.153. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.154. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.155. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.156. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.157. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.158. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.159. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.160. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.161. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.162. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.163. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.164. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.165. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.166. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.167. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.168. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.169. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.170. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.171. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.172. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.173. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.174. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.175. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.176. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.177. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.178. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.179. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.180. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.181. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.182. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.183. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.184. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.185. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.186. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.187. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.188. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.189. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.190. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.191. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.192. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.193. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.194. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.195. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.196. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.197. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.198. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.199. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.200. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.201. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.202. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.203. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.204. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.205. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.206. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.207. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.208. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.209. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.210. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.211. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.212. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.213. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.214. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.215. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.216. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.217. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.218. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.219. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.220. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.221. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.222. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.223. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.224. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.225. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.226. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.227. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.228. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.229. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.230. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.231. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.232. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.233. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.234. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.235. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.236. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.237. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.238. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.239. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.240. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.241. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.242. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.243. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.244. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.245. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.246. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.247. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.248. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.249. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.250. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.251. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.252. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.253. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.254. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.255. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.256. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.257. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.258. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.259. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.260. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.261. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.262. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.263. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.264. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.265. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.266. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.267. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.268. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.269. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.270. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.271. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.272. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.273. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.274. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.275. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.276. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.277. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.278. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.279. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.280. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.281. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.282. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.283. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.284. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.285. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)

List of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  1. 1087systems
  2. 48Hour Discovery
  3. 5AM Ventures
  4. Abbott
  5. AbbVie
  6. Academia Sinica
  7. Academic Medical Centre
  8. Academy of Military Medical Sciences
  9. Accelerate Diagnostics
  10. ACEA Biosciences
  11. AcouSort
  12. Active Biotech
  13. Adaptive Biotechnologies
  14. Adelaide Research & Innovation
  15. AdnaGen
  16. ADS BIOTEC
  17. Advanced Virus Detection Technologies Interest Group
  18. Aegea Biotechnologies
  19. Aenitis Technologies
  20. Agency for Science, Technology and Research
  21. Agilent Technologies
  22. AIM Group International
  23. AIMM Therapeutics
  24. Akadeum Life Sciences
  25. Albert Einstein College of Medicine
  26. Alder BioPharmaceuticalss
  27. Alexion Pharmaceuticals
  28. Alkem Laboratories
  29. Amazentis
  30. Ambergen
  31. American Institute of Health
  32. Amgen
  33. AnaptysBio
  34. Ancera
  35. Angel HQ
  36. Angel Round Capital Fund
  37. ANGLE
  38. Ann & Robert H Lurie Children's Hospital of Chicago
  39. ANSYS
  40. Anzu Partners
  41. ApoCell
  42. Argonaut Manufacturing Services
  43. arivis
  44. Artiman Ventures
  45. Ascent Bio-Nano Technologies
  46. Ascus Biosciences
  47. Astellas Pharma
  48. Augusta University
  49. Aurora Life Technologies
  50. AVIVA Biosciences
  51. Barts Cancer Institute
  52. Base4 Innovation
  53. Bay City Capital
  54. Bayer
  55. BC Cancer Agency
  56. Beckman Coulter
  57. Becton Dickinson
  58. Beijing Genomics Institute
  59. Beth Israel Deaconess Medical Center 
  60. Betta Pharmaceuticals
  61. BGI Group
  62. Biocept
  63. Bioceptive
  64. BioCrine 
  65. BioFluidica
  66. BioInfleXion Point Partners
  67. BIOKÉ
  68. Biolidics
  69. BioMEMS Resource Center
  70. BioMimetic Therapeutics
  71. Bio-Rad Laboratories
  72. BIOSS
  73. Bio-Techne 
  74. BioTheranostics
  75. BioView
  76. Boehringer Ingelheim 
  77. Boyalife Group
  78. Bpifrance
  79. Brigham and Women's Hospital
  80. Bristol-Myers Squibb
  81. Broad Institute
  82. Bucher Biotec
  83. C4 Therapeutics
  84. California Institute of Technology
  85. California NanoSystems Institute
  86. Caltag Medsystems
  87. Cambridge Consultants
  88. Cambridge Enterprise
  89. Canary Center at Stanford
  90. Cancer Genetics
  91. Cancer Institute of Greenville Health System
  92. Cancer Metastasis Laboratory, University of Basel
  93. Cancer Research UK Manchester Institute
  94. CANCER-ID
  95. Canon US Life Sciences
  96. Capio Biosciences
  97. Caris Life Sciences
  98. Carnegie Mellon University
  99. Case Western Reserve University
  100. Catalyst Biosciences
  101. Celgene
  102. Cell Microsystems
  103. Cell Signaling Technology
  104. Cell.Copedia 
  105. Cellaviva
  106. CellectCell
  107. Cellenion
  108. Cellix
  109. CellMax Life
  110. Celsee
  111. Center for Advanced Medical Products
  112. Centre Léon Bérard
  113. Cephalon
  114. Cesca Therapeutics
  115. CFD Research
  116. Chang Gung Memorial Hospital
  117. ChemoCentryx
  118. Chinese Academy of Medical Sciences
  119. Cincinnati Children's Hospital Medical Center
  120. Cipla
  121. Clinomics
  122. Columbia University
  123. Cornell University
  124. Corning
  125. Creative BioArray
  126. Creative Diagnostics
  127. CREST
  128. CRV International
  129. CureGene
  130. Cytonome
  131. CytoVale 
  132. Cytovance Biologics
  133. Dana-Farber Cancer Institute
  134. Danaher
  135. DAON BioSciences
  136. Decheng Capital
  137. Department of Biomedical Engineering, Lund University
  138. Detroit Innovate
  139. DiaSorin
  140. Diffusion Capital Partners
  141. Draper Laboratory
  142. Duke University
  143. eFFECTOR Therapeutics
  144. Eisai
  145. EKF Diagnostics
  146. eLab Ventures
  147. Eli Lilly 
  148. EMV Capital
  149. Engender Technologies
  150. Enlivex Therapeutics
  151. Enterprise Angels
  152. Epic Sciences
  153. Evercyte 
  154. EXONBio
  155. Fiona Stanley Hospital
  156. Five3 Genomics
  157. FloDesign Sonics
  158. Florida Cancer Specialists and Research Institute
  159. Fluidigm
  160. France Innovation Scientifique et Transfert
  161. French National Center for Scientific Research 
  162. Fudan University Shanghai Cancer Center
  163. FusionX Ventures
  164. GE Healthcare
  165. GenapSys
  166. Genentech
  167. General Automation Lab Technologies
  168. Genewiz
  169. Genial Laboratory Automation
  170. Genoa Ventures
  171. Georgetown University
  172. Georgia Tech Research Institute
  173. Gilead Sciences
  174. GILUPI
  175. Glass Capital Management
  176. GlaxoSmithKline
  177. Glenmark Pharmaceuticals 
  178. GOM
  179. Grace Bio-Labs
  180. Greenwoods Asset Management
  181. GRI Bio
  182. Guangxi Academy of Sciences
  183. Hahn-Schickard 
  184. Halcyon Biomedical
  185. Halozyme Therapeutics
  186. Harvard Stem Cell Institute
  187. Harvard University
  188. Horizon Discovery
  189. Hubei Cancer Clinical Study Center
  190. Humacyte 
  191. Humanitas Research Hospital
  192. Hunan Agen Medicine Laboratory Technology
  193. IBA Lifesciences
  194. Icahn School of Medicine
  195. ICE Angels
  196. iCellate
  197. ICREA
  198. Ignyta
  199. Illumina Ventures
  200. IMEC
  201. immatics biotechnologies
  202. Immunomedics
  203. ImmunoQure 
  204. Inabata 
  205. Inbiomotion
  206. IncellDx
  207. IncoCell Tianjin
  208. Incyte 
  209. Inguran
  210. Innate Pharma
  211. Innovate UK
  212. Innovative Biochips
  213. Innovative Micro Technology
  214. Inova 
  215. Institute of Cancer Research, London
  216. Institute of Organic Chemistry and Biochemistry
  217. Instrumentation Laboratory 
  218. Intrinsic LifeSciences
  219. Invention Science Fund
  220. Invest Michigan
  221. Invetech 
  222. iPS Portal
  223. Janssen Biotech
  224. Japan Science and Technology Agency
  225. Jiulongpo District People's Hospital 
  226. Jiva Sciences
  227. John Hopkins University
  228. John Wayne Cancer Institute
  229. Jonsson Comprehensive Cancer Center
  230. Karolinska Institute
  231. Kataoka
  232. Katholieke Universiteit Leuven
  233. Keswick Ventures
  234. Kiyatec
  235. Koek Biotechnology
  236. Kymab
  237. LabCorp
  238. Landos Biopharma
  239. Lawson Health Research Institute
  240. Leica Biosystems
  241. LevitasBio
  242. LG Electronics 
  243. LIDE Biotech
  244. Life Technologies
  245. Livzon Pharmaceuticals
  246. London Business Angels
  247. LPATH
  248. LumaCyte
  249. Luminex
  250. LungLifeAI
  251. Lupin
  252. Mackay Memorial Hospital 
  253. Massachusetts Institute of Technology
  254. Mayo Clinic Foundation
  255. MD Anderson Cancer Center
  256. MDxK
  257. Medigen Biotech
  258. MeMed Diagnostics
  259. Memorial Sloan Kettering Cancer Center
  260. Menarini Silicon Biosystems
  261. Merck
  262. Metabiota
  263. Microbix Biosystems
  264. MicroMedicine
  265. Middle East Technical University
  266. Mikro Biyosistemler
  267. Mikro Systems
  268. Millennium Pharmaceuticals
  269. MilliporeSigma
  270. Miltenyi Biotec
  271. Morehouse School of Medicine 
  272. Morphotek
  273. Mumbai Angels 
  274. Namocell
  275. NanoCellect Biomedical
  276. Nanosphere
  277. NanoTag Biotechnologies
  278. National Cancer Centre Singapore
  279. National Cancer Institute
  280. National Center for Emerging and Zoonotic Infectious Diseases
  281. National Center for Nanoscience and Technology 
  282. National Institute for Health Research
  283. National Institute for Innovation in Manufacturing Biopharmaceuticals
  284. National Institute of Drug Abuse
  285. National Institute of General Medical Sciences
  286. National Institutes of Health
  287. National University Hospital
  288. National University of Ireland Galway’s Regenerative Medicine Institute
  289. National University of Singapore
  290. Naval Research Laboratory
  291. Nektar Therapeutics
  292. NeoDiagnostix
  293. NeuroVision Pharma
  294. New York Upstate Cord Blood Bank
  295. New Zealand Venture Investment Fund
  296. Newable Private Investing
  297. NextGem
  298. Nodality
  299. Northeastern University
  300. Northwestern University
  301. Novartis
  302. Novo Nordisk
  303. Ohio State Innovation Foundation
  304. On-chip Biotechnologies
  305. Oregon Health & Science University
  306. Organovo
  307. Ortho Clinical Diagnostics
  308. Orthohealing Center Management
  309. Osaka University Venture Capital
  310. Owl biomedical
  311. OYAK
  312. Pacific Biosciences
  313. Pacific Channel
  314. Packers Sanitation Services
  315. Parkwalk Advisors
  316. Partec
  317. Penn State Research Foundation
  318. PerkinElmer
  319. Pfizer
  320. Pharmaxis
  321. Philips
  322. Phywe
  323. pluriSelect Life Science
  324. Purdue Research Foundation
  325. Qiagen
  326. Quad Technologies 
  327. Qventures
  328. R&D Systems
  329. RareCyte
  330. Real Tech Fund
  331. Regeneron Pharmaceuticals
  332. Regionalt Cancercentrum Stockholm-Gotland
  333. RIKEN Bioresource Research Center 
  334. Riverside’s Highlander Venture Fund
  335. Roche
  336. Roswell Park Comprehensive Cancer Center
  337. Rowan University
  338. Rush University Medical Center
  339. Samsung Medical Center 
  340. Sandoz
  341. Sanford Burnham Prebys Medical Discovery Institute
  342. Scholar Rock
  343. ScreenCell
  344. Seoulin Bioscience
  345. Sequenom
  346. Sequenta
  347. Seventure Partners
  348. Severance Hospital 
  349. Shilps Sciences
  350. Shriners Hospitals for Children
  351. Singapore General Hospital
  352. Singapore Immunology Network 
  353. Singapore-MIT Alliance for Research and Technology 
  354. Singh Molecular Medicine
  355. Singular BIO
  356. Sir Charles Gairdner Hospital
  357. Siwa Therapeutics
  358. Skåne University Hospital
  359. Sloan Kettering Institute
  360. Sony Biotechnology
  361. Southampton General Hospital 
  362. Sphere Fluidics
  363. SpheriTech
  364. SRI International
  365. Stand Up To Cancer
  366. Stanford University
  367. Stanford Women's Cancer Center
  368. StemBioSys
  369. Stempeutics Research
  370. Stony Brook University
  371. Streck
  372. Sumitomo Dainippon Pharma
  373. Sutter Health
  374. Syllogistech
  375. SynGen Biotech
  376. Syno Capital
  377. Sysmex 
  378. Takeda Pharmaceutical 
  379. Tan Tock Seng Hospital
  380. Targeted Technology Fund
  381. Technical University of Denmark
  382. Telegraph Hill Partners
  383. Texas Stem Cell
  384. The Fourth People's Hospital of Chongqing
  385. Theranosis Life Sciences
  386. Thermo Fisher Scientific 
  387. ThermoGenesis
  388. ThinkCyte
  389. Tisch Cancer Institute
  390. Tokai Pharmaceuticals
  391. TOMY Digital Biology
  392. TorpedoDx
  393. Tracon Pharmaceuticals
  394. Trinity College Dublin
  395. TumorGenesis 
  396. Twist Bioscience
  397. Tyme
  398. UCB Biopharma
  399. UCLA Medical Center
  400. Union Biometrica
  401. United States Army Medical Research Institute for Infectious Diseases
  402. United States Environmental Protection Agency
  403. University of British Columbia
  404. University of California
  405. University of Chicago
  406. University of Edinburgh
  407. University of Illinois at Urbana-Champaign
  408. University of Iowa Research Foundation
  409. University of Kansas
  410. University of Maryland
  411. University of Miami
  412. University of Michigan
  413. University of Missouri
  414. University of North Carolina
  415. University of Notre Dame
  416. University of Oxford John Radcliffe Hospital
  417. University of Pennsylvania
  418. University of Southern California Norris Comprehensive Cancer Center
  419. University of Texas
  420. University of Utah
  421. University of Virginia School of Medicine
  422. Uppsala University
  423. US Department of Veterans Affairs
  424. Vancouver Prostate Centre
  425. Vanderbilt University
  426. Vegenics 
  427. VentureSouth
  428. Vertical Venture Partners
  429. Vortex Biosciences
  430. VWR
  431. Wako Pure Chemical Industries
  432. Washington University
  433. Wego Medical Systems
  434. Whitehead Institute for Biomedical Research
  435. Woods Hole Oceanographic Institution
  436. Wright State University
  437. Xcell Biosciences
  438. Yale University
  439. Zeiss
  440. Zhongnan Hospital of Wuhan University
  441. Zomedica Pharmaceuticals
  442. Zurich Instruments
  443. ZymoGenetics

Segmentation

The financial opportunity within the novel cell sorting and separation market has been analyzed across the following segments:

  • Type of offering
    • Cell sorters
    • Consumables and isolation kits
  • Potential application area
    • Research studies 
    • Circulating tumor cell detection 
    • In vitro fertilization
    • Non-invasive prenatal diagnosis
    • Cell-based therapeutics 
  • Cell sorting technology
    • Buoyancy-activated
    • Magnetophoretics
    • Microfluidics
    • Optoelectronics
    • Other advanced technologies
  • Type of cell
    • Animal cells
    • Cancer cells
    • Immune cells
    • Microbial cells
    • Red blood cells / platelets
    • Stem cells
  • Key geographical regions
    • North America
    • Europe
    • Asia Pacific

PRICING DETAILS

USD 4,499

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com